The only concern is the banking index, which has shown a relative underperformance. But this index is still in a consolidation phase, and there's a good probability of some buying interest emerging. This would further support the benchmark, says one analyst.

Hot Stocks | Can bet on Dr. Reddy's Labs, HDFC Bank and Hindalco for the short term

Near-term support for Nifty is placed near the 15,650 level and once the previous high of 15,915 is sustainably breached, it could rise towards the 16,000 mark and even higher.

As second wave of COVID-19 may hamper some economic growth in FY22, buy these 8 stocks amid correction

There could be some impact of COVID-19 on economic and earnings growth -- at least in the first quarter of FY22. This would ultimately hit full-year growth to some extent, but there could be faster recovery, post the second wave.

Analysts suggest these 8 large-cap stocks to buy at this juncture, do you own any?

In these uncertain times, when markets are volatile as the country grapples with the frightening rise in COVID-19 infections, experts say investors should go for quality large-cap stocks and use any near-term correction to pick up such shares.

Macquarie expects over 20% upside in these 7 largecaps; feels this midcap stock can turn multibagger

LIC Housing Finance is the fresh addition in its portfolio as it is a value play (1.0x PBV) supported by pick up in home loan demand, and builder NPL resolutions

Budget 2021 | Focus on healthcare but mixed bag for pharma, 9 stocks you can pick from sector

The sector was in focus in Union Budget 2021. Finance Minister Nirmala Sitharaman in her Budget speech announced an outlay of Rs 2,23,846 crore for health and well being.

Hot Stocks | Can bet on Dr Reddy's Labs, Max Financial for short-term

The weekly candle gives the replica of a hanging man candlestick pattern but one needs to wait for the next week's candle for the confirmation.

HCL Tech, Sun Pharma among 10 largecap names that can give 8-30% returns in a year

Analysts and brokerage firms are bullish on market prospects as events such as the US election is over and positive reports on the vaccine front are giving hopes that soon COVID-19 will be under control.

Be ready for Samvat 2077! Brokerages pick 15 largecaps for 14-48% upside by next Diwali

Prabhudas Lilladher believes that current uncertainty is a passing phase and return to normalcy will result in several beaten down segments bouncing back strongly from FY22.

Good time to build a portfolio, brokerages pick 20 stocks for 13-49% return

With midcaps and smallcaps expected to outperform largecaps, especially after September quarter earnings, this is the right time to build a portfolio, analysts have said.

Analysts upgrade 31 stocks to 'buy' after Q2 earnings, can return 10-50%

The benchmark indices and broader markets have rallied more than 55 percent from the lows of March 23, though they have been some correction in the last few sessions.

Market may be heading to record high; brokerages bet on these 8 blue-chip stocks

While the market has rallied smartly, the rally has been highly concentrated with the top 15 stocks contributing over 70 percent of the returns.

Experts bet on these 18 stocks after Q1 earnings; do you own any?

IT and pharma are preferred themes by experts after June quarter earnings

A V-shape recovery unlikely; brokerages are betting on these 10 largecaps

Interventions by governments and central banks have prevented the economic situation from deteriorating significantly but it is unlikely that the recovery will be a V-shaped one, say experts.

Nifty in overbought state, but make fresh shorts only if it breaks 10,300: Sacchitanand Uttekar

Technically the index has been scaling higher with narrow ranged candles but the momentum indicators are diverging & indicating lack of strength.

Pharma: Is the show over or are there some fireworks left?

After some tough years, the pharma sector is performing well and is around 25 percent up while the broader market is down 20 percent year-to-date.

Telecom, healthcare, consumer may dominate post-COVID world; 12 stocks to look at

Experts and analysts expect a change in market leadership in the post-COVID world in which telecom, healthcare, speciality chemicals, and rural consumers may dominate other sectors.

Hot Stocks | Tech Mahindra, Dr Reddy's Labs, UBL can give up to 11% return in short term

On the higher side, 10,334 - 10,351 will continue to act as a stiff resistance zone for Nifty which needs to be taken out on a closing basis for the extension of the rally.

Building portfolio: Experts bet on 21 scrips to create wealth in coming years

Aashish Somaiyaa of Motilal Oswal Asset Management Company advised that one should avoid panic and remain invested.

Market stares at an uncertain tomorrow; 12 stocks that can still reap gains

Experts continue to warn that the market will keep oscillating between rise and fall and one must remain cautious while taking a call for trade.

Pharma index up 45% from March lows; CLSA says earnings momentum to continue, raises targets

The Nifty Pharma index gained half a percent on May 7, taking gains to around 45 percent since March 23.

Brokerages recommend these 12 stocks in time of uncertainty; do you own any?

Experts point out that the COVID-19 pandemic came in stages across the world and its fading away also will happen in phases over the next few quarters.

Pharma sector sits pretty amid market turmoil; 5 stocks that you can buy

The panic created by COVID-19 has taken a heavy toll on most sectors but pharma companies seem to have withstood the carnage, with some stocks delivering healthy returns during this period.

Nifty likely to trade in 8,000-9,000 range; 5 stocks for 1-3 months investment

If VIX sustains above 50 levels, then pressure can be seen in the market. It needs to move below 40 levels for stability to return in the market.

Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

Sudarshan Sukhani of s2analytics.com recommends buying Asian Paints with stop loss at Rs 1825 and target of Rs 1890 and Pidilite Industries with stop loss at Rs 1540 and target of Rs 1645.